Latest stories on CAI
Caris Life Sciences, Inc. (CAI) files 8-K
SEC 8-K50 · neutralgeneral
Caris Life Sciences Eyes Bigger Oncology Market After IPO as Revenue Jumps 79%
Yahoo Finance67 · bullishproduct/pr
Caris Life Sciences Submits Application to New York State Department of Health for Caris Assure Blood‑Based Testing Authorization
PR Newswire58 · neutralproduct/pr
Caris (CAI) Q1 2026 Earnings Call Transcript
Yahoo Top50 · neutralearnings
Caris Life Sciences Reports First Quarter 2026 Financial Results
PR Newswire77 · bullishearnings